Fmc Corporation · NYSE:FMC

Fmc — UBS Warburg Meetings 2003

22 slides from Fmc's conference presentation, Sep 4, 2003

  1. Slide 1: FMC Corporation - UBS Warburg Meetings

    Exhibit 99.1 [logo] FMC Corporation UBS Warburg Meetings September 2nd – 4th, 2003 William G. Walter Chairman, President and CEO

  2. Slide 2: Disclaimer

    [LOGO] Disclaimer Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: These slides and the accompanying presentation contain “forward-looking statements” that represent management’s best judgment as of the date hereof based on information currently available. Actual res

  3. Slide 3: FMC Corporation

    [LOGO] FMC Corporation Diversified chemical company with leading market positions in agricultural, industrial and consumer markets globally ($ million, 12/31/02) FMC Sales: $1,852.9 EBITDA: $313.7 Margin: 16.9% Agricultural Products Specialty Chemicals Industrial Chemicals Sales: $615.1 Sales: $488.

  4. Slide 4: Agricultural Products Group Overview

    [LOGO] Agricultural Products Group Overview 2002 Consolidated Sales: $615.1 million [PIE CHART] [PIE CHART] · Manufacturer of proprietary, branded insecticides and herbicides · Key crops: cotton, corn, rice, cereals and vegetables · FMC differentiated by: —Concentration in insecticides —Focus on sel

  5. Slide 5: Agricultural Products Financial Performance

    [LOGO] Agricultural Products Financial Performance ($ in millions) Historical Performance [BAR CHART] —Global crop recession since 1997 —Sulfentrazone row crop peak in 2000 —Steady ‘00 -’02 sales growth in pyrethroid insecticides of 5% CAGR —2002 refocusing on insecticides, key crops and select regi

  6. Slide 6: Growth in Agricultural Products

    [LOGO] Growth in Agricultural Products • Near-term growth is in our core, patented products representing nearly 45% of total sales: — Bifenthrin insecticide driven predominately by corn — Zeta-cypermethrin insecticide driven by 9 new labels — Carfentrazone post-emergent herbicide driven by 4 new lab

  7. Slide 7: Specialty Chemicals Group Overview

    [LOGO] Specialty Chemicals Group Overview 2002 Consolidated Sales: $488.2 million [PIE CHART] [PIE CHART] · BioPolymer: — Adds structure, texture and stability to food — Acts as a binder & disintegrant for dry tablet drugs — Market leader in each product line · Lithium: — One of two global, integrat

  8. Slide 8: Specialty Chemicals Financial Performance

    [LOGO] Specialty Chemicals Financial Performance ($ in millions) Historical Performance — Strong ‘00 -’02 BioPolymer unit growth of over 5% CGR: • Demand for dry tablet pharmaceuticals [BAR CHART] • Health and convenience demands in food — Decline in lithium sales: • SQM entry into lithium carbonate

  9. Slide 9: Growth in BioPolymer

    [LOGO] Growth in BioPolymer Food Ingredients Pharmaceutical Formulation Market FMC Market FMC Growth Share Growth Share Cellulosics 5% #1 Binders 5% #1 Carrageenan 4% #1 Hydrocolloids 4% #1 Alginates 3% #2 Disintegrants 4% #2 • Competitive advantage: • Competitive advantage: – Breadth of product lin

  10. Slide 10: Growth in Lithium

    [LOGO] Growth in Lithium Growth profile to improve substantially beginning in 2003 · Solid growth in polymer markets of 4-6%: – Key products: lithium metals, butyllithium, specialty organometallics – Uses: polymer synthesis and initiation – 28% of FMC Lithium sales · Strong growth in pharmaceutical

  11. Slide 11: Industrial Chemicals Group Overview

    [LOGO] Industrial Chemicals Group Overview 2002 Consolidated Sales: $753.4 million [PIE CHART] [PIE CHART] Excludes phosphorus chemicals sales at Astaris JV of $445.7 million, largely in North America • #1 North American manufacturer of soda ash, peroxygens and phosphorus chemicals • Backward integr

  12. Slide 12: Industrial Chemicals Financial Performance

    [LOGO] Industrial Chemicals Financial Performance ($ in millions) Historical Performance [BAR CHART] — ‘01-’02 recession and overcapacity — Capacity mothballs and shutdowns: • Soda ash mothball: 1.3 mil. tons • Hydrogen peroxide mothball: 100 mil. lbs • Shutdown of Astaris elemental phosphorus plant

  13. Slide 13: Price Recovery in Hydrogen Peroxide

    [logo] Price Recovery in Hydrogen Peroxide About ~1 cent per lb. increase in hydrogen peroxide has been achieved in 2003 and several more cents possible in 2004 [LINE CHART]

  14. Slide 14: Improving Price Outlook for Soda Ash

    [LOGO] Improving Price Outlook for Soda Ash Soda ash price announcements for 2004 have begun, while rumors surrounding industry consolidation continue [LINE CHART] Source: Isonex/USGS and FMC

  15. Slide 15: Bottoming in Phosphorus Chemicals

    [LOGO] Bottoming in Phosphorus Chemicals In North America, Astaris to be down over $20 million vs. 2002 (FMC basis). In Europe, Foret to be relatively flat vs. 2002. [BAR CHART] [BAR CHART] · End of power resale contract (Astaris only) · Shift to low cost purified phosphoric acid (Astaris only) · De

  16. Slide 16: FMC's Strengths

    [LOGO] FMC’s Strengths Strong businesses in a diversified portfolio · Leading market positions · Global presence · Diversified business mix and high-quality customer base · Diversified and integrated cost structure · Focused R&D and strong applications expertise · Proven management with extensive in

  17. Slide 17: FMC Valuation

    [LOGO] FMC Valuation For all our strengths, we continue to be grossly undervalued Enterprise Value to Trailing EBITDA (as of August 31st, 2003) [BAR CHART] S&P 400 Chemicals Index Components Source: Bloomberg Financial andSEC Filings

  18. Slide 18: Unlocking Shareholder Value

    [LOGO] Unlocking Shareholder Value · Maximize and realize operating leverage · Create greater financial flexibility · Focus the portfolio on higher growth businesses

  19. Slide 19: Maximize and Realize Operating Leverage

    [LOGO] Maximize and Realize Operating Leverage · Reduce costs in Industrial Chemicals to enhance impact of recovery · Grow Agricultural Products and Specialty Chemicals profit · Deploy free cash flow to reduce $300 million of debt by end of 2006 [CHART]

  20. Slide 20: Create Greater Financial Flexibility

    [LOGO] Create Greater Financial Flexibility Debt reduction to begin in 2004 ($ in millions) TROUGH 2003 EBITDA* $300-305 Less normal: Net interest expense ($100) Capital spending (70% of D&A) (85) Environmental spending (legacy) (25) NORMAL TROUGH FREE CASH FLOW* $ 90-95 Less 2003: Pocatello-related

  21. Slide 21: Focus Portfolio on Higher Growth Businesses

    [LOGO] Focus Portfolio on Higher Growth Businesses · Selectively grow our more attractive businesses, managing the balance of our portfolio for cash – Leverage growth platforms in Specialty and Ag – Manage Industrial Chemicals for cash · Focus the portfolio on businesses in which FMC is the natural

  22. Slide 22: FMC Corporation

    FNC FMC Corporation [LOGO] FMC Corporation

FMC — UBS Warburg Meetings 2003 on 6ix